Relevance of electrical remodeling in human atrial fibrillation results of the asymptomatic atrial fibrillation and stroke evaluation in pacemaker patients and the atrial fibrillation reduction atrial pacing trial mechanisms of atrial fibrillation study

Circulation: Arrhythmia and Electrophysiology

Volumn 5, Issue 4, 2012, Pages 626-631

  Healey, Jeff S ^a   Israel, Carsten W ^b   Connolly, Stuart J ^a   Hohnloser, Stefan H ^c   Nair, Girish M ^a   Divakaramenon, Syamkumar ^a   Capucci, Alessandro ^d   Van Gelder, Isabelle C ^e   Lau, Chu Pak ^f   Gold, Michael R ^g   Carlson, Mark ^h   Themeles, Ellison ^a   Morillo, Carlos A ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b EVANGELISCHES KRANKENHAUS   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f UNIVERSITY OF HONG KONG   (Hong Kong)

^g MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^h ST JUDE MEDICAL   (United States)

Author keywords

Atrial fibrillation; Electrophysiology; Hypertension; Pacemakers; Remodeling

Indexed keywords

ADAPTATION; AGED; ARTICLE; CLINICAL FEATURE; FEMALE; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE REFRACTORY PERIOD; HUMAN; MAJOR CLINICAL STUDY; MALE; P WAVE; PREDICTOR VARIABLE; PRIORITY JOURNAL; SUPRAVENTRICULAR TACHYCARDIA;

ACTION POTENTIALS; AGED; AGED, 80 AND OVER; ASYMPTOMATIC DISEASES; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; EQUIPMENT DESIGN; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; MALE; PACEMAKER, ARTIFICIAL; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REFRACTORY PERIOD, ELECTROPHYSIOLOGICAL; RISK ASSESSMENT; RISK FACTORS; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84867156602     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.112.970442     Document Type: Article

References (30)

1. Skanes AC, Krahn AD, Yee R, Klein GJ, Connolly SJ, Kerr CR, Gent M, Thorpe KE, Roberts RS; Canadian Trial of Physiologic Pacing. Progression to chronic atrial fibrillation after pacing: the Canadian Trial of Physiologic Pacing. CTOPP Investigators. J Am Coll Cardiol. 2001;38:167-172. (Pubitemid 32613845)
2. Healey JS, Toff WD, Lamas GA, Andersen HR, Thorpe KE, Ellenbogen KA, Lee KL, Skene AM, Schron EB, Skehan JD, Goldman L, Roberts RS, Camm AJ, Yusuf S, Connolly SJ. Cardiovascular outcomes with atrialbased pacing compared with ventricular pacing: meta-analysis of randomized trials, using individual patient data. Circulation. 2006;114:11-17. (Pubitemid 44305269)
3. Sweeney MO, Bank AJ, Nsah E, Koullick M, Zeng QC, Hettrick D, Sheldon T, Lamas GA; Search AV Extension and Managed Ventricular Pacing for Promoting Atrioventricular Conduction (SAVE PACe) Trial. Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease. N Engl J Med. 2007;357:1000-1008. (Pubitemid 47367079)
4. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol. 1998;82(8A):2N-9N. (Pubitemid 28507114)
5. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995;98:476-484.
6. Morillo CA, Klein GJ, Jones DL, Guiraudon CM. Chronic rapid atrial pacing: structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation. 1995;91:1588-1595.
7. Wijffels MC, Kirchhof CJ, Dorland R, Allessie M.A. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation. 1995;92:1954-1968.
8. Li D, Fareh S, Leung TK, Nattel S. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation. 1999;100:87-95. (Pubitemid 29297945)
9. Sanders P, Morton JB, Davidson NC, Spence SJ, Vohra JK, Sparks PB, Kalman JM. Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans. Circulation. 2003;108:1461-1468. (Pubitemid 37176452)
10. Sparks PB, Mond HG, Vohra JK, Jayaprakash S, Kalman JM. Electrical remodeling of the atria following loss of atrioventricular synchrony: a long-term study in humans. Circulation. 1999;100:1894-1900. (Pubitemid 29511143)
11. Kumagai K, Nakashima H, Urata H, Gondo N, Arakawa K, Saku K. Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation. J Am Coll Cardiol. 2003;41:2197-2204. (Pubitemid 36724267)
12. Franz MR, Karasik PL, Li C, Moubarak J, Chavez M. Electrical remodeling of the human atrium: similar effects in patients with chronic atrial fibrillation and atrial flutter. J Am Coll Cardiol. 1997;30:1785-1792. (Pubitemid 27521263)
13. Healey JS, Theoret-Patrick P, Green MS, Lemery R, Birnie D, Tang AS. Reverse atrial electrical remodelling following atrial defibrillation as determined by signal-averaged ECG. Can J Cardiol. 2004;20:311-315. (Pubitemid 38477486)
14. John B, Stiles MK, Kuklik P, Brooks AG, Chandy ST, Kalman JM, Sanders P. Reverse remodeling of the atria after treatment of chronic stretch in humans: implications for the atrial fibrillation substrate. J Am Coll Cardiol. 2010;55:1217-1226.
15. Israel CW, Grönefeld G, Ehrlich JR, Li YG, Hohnloser SH. Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. J Am Coll Cardiol. 2004;43:47-52. (Pubitemid 38045914)
16. Daoud EG, Bogun F, Goyal R, Harvey M, Man KC, Strickberger SA, Morady F. Effect of atrial fibrillation on atrial refractoriness in humans. Circulation. 1996;94:1600-1606. (Pubitemid 26320264)
17. Hohnloser SH, Capucci A, Fain E, Gold MR, van Gelder IC, Healey J, Israel CW, Lau CP, Morillo C, Connolly SJ; ASSERT Investigators and Committees. ASymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the atrial fibrillation Reduction atrial pacing Trial (ASSERT). Am Heart J. 2006;152:442-447. (Pubitemid 44233420)
18. Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, Lau CP, Fain E, Yang S, Bailleul C, Morillo CA, Carlson M, Themeles E, Kaufman ES, Hohnloser SH. Pacemaker-detected atrial tachyarrhythmias and the risk of stroke. N Engl J Med. 2012;366:122-131.
19. Healey JS, Israel CW, Capucci A, Van Gelder IC, Lau CP, Fain E, Gold MR, Yang S, Morillo CA, Bailleul C, Hohnloser SH, Connolly SJ. Ambulatory electrophysiologic properties in pacemaker patients with sinus node disease compared with atrioventricular node disease. Can J Cardiol. 2008;24:840.
20. Anyukhovsky EP, Sosunov EA, Chandra P, Rosen TS, Boyden PA, Danilo P Jr, Rosen MR. Age-associated changes in electrophysiologic remodeling: a potential contributor to initiation of atrial fibrillation. Cardiovasc Res. 2005;66:353-363. (Pubitemid 40471050)
21. Okin PM, Wachtell K, Devereux RB, Harris KE, Jern S, Kjeldsen SE, Julius S, Lindholm LH, Nieminen MS, Edelman JM, Hille DA, Dahlöf B. Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension. JAMA. 2006;296:1242-1248. (Pubitemid 44394895)
22. Gerdts E, Oikarinen L, Palmieri V, Otterstad JE, Wachtell K, Boman K, Dahlöf B, Devereux RB; Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. Hypertension. 2002;39:739-743. (Pubitemid 34252867)
23. Madu EC, Baugh DS, Gbadebo TD, Dhala A, Cardoso S; Phi-Res Multi-Study Group. Effect of ethnicity and hypertension on atrial conduction: evaluation with high-resolution P-wave signal averaging. Clin Cardiol. 2001;24:597-602. (Pubitemid 32816643)
24. Tsang TS, Barnes ME, Bailey KR, Leibson CL, Montgomery SC, Takemoto Y, Diamond PM, Marra MA, Gersh BJ, Wiebers DO, Petty GW, Seward JB. Left atrial volume: important risk marker of incident atrial fibrillation in 1655 older men and women. Mayo Clin Proc. 2001; 76:467-475. (Pubitemid 32423130)
25. Fujiki A, Sakabe M, Nishida K, Mizumaki K, Inoue H. Role of fibrillation cycle length in spontaneous and drug-induced termination of human atrial fibrillation. Circ J. 2003;67:391-395.
26. Capucci A, Biffi M, Boriani G, Ravelli F, Nollo G, Sabbatani P, Orsi C, Magnani B. Dynamic electrophysiological behavior of human atria during paroxysmal atrial fibrillation. Circulation. 1995;92:1193-1202.
27. Spach MS, Dolber PC. Relating extracellular potentials and their derivatives to anisotropic propagation at a microscopic level in human cardiac muscle: evidence for electrical uncoupling of side-to-side fiber connections with increasing age. Circ Res. 1986;58:356-371. (Pubitemid 16120759)
28. Kristensen L, Nielsen JC, Mortensen PT, Christensen PD, Vesterlund T, Pedersen AK, Andersen HR. Sinus and paced P wave duration and dispersion as predictors of atrial fibrillation after pacemaker implantation in patients with isolated sick sinus syndrome. Pacing Clin Electrophysiol. 2004;27:606-614. (Pubitemid 38648450)
29. De Sisti A, Leclercq JF, Stiubei M, Fiorello P, Halimi F, Attuel P. P wave duration and morphology predict atrial fibrillation recurrence in patients with sinus node dysfunction and atrial-based pacemaker. Pacing Clin Electrophysiol. 2002;25:1546-1554. (Pubitemid 35398913)
30. Healey JS, Connolly SJ. Atrial fibrillation: hypertension as a causative agent, risk factor for complications, and potential therapeutic target. Am J Cardiol. 2003;91(10A):9G-14G. (Pubitemid 36638516)